Instruction for use: Engystol

Pharmacological group

Homeopathic Remedies

Nosological classification (ICD-10)

D84.9 Immunodeficiency, unspecified

Pneumonia in immunodeficiency states, Autoimmune disease, Autoimmune diseases, Significant immunodeficiency, Immune Deficiency, Immunodeficiency, Immunodeficiency diseases, Immunodeficiency conditions due to surgical intervention, Immunocorrection for cancer, Immunomodulation, Infections in Patients with Weakened Immunity, Correction of immune deficiency, Correction of immunodeficiency states, Correction of weakened immunity, Correction of weakened immunity in immunodeficient states, Impaired immunity, Infringement of the immune status, Impaired immune system, Primary immunodeficiency, Maintenance of immunity, Reduction of protective forces, Decreased immunity, Decreased immunity for colds and infectious diseases, Decreased immune status, Reduced resistance to infectious diseases, Reduced resistance to infectious and catarrhal diseases, Reduced resistance of the body, Low immunity, Predisposition to colds, Acquired immunodeficiency, Radiation immunodeficiency, Development of immunodeficiency, The syndrome of immune dysfunction, Immunodeficiency Syndrome, Syndrome of primary immunodeficiency, Reduction of body defenses, Decreased immunity, Decreased body immune defense, Decreased local immunity, Decrease in the total body resistance, Reduction of cellular immunity, Reduced resistance to infections in children, Decreased body resistance, Reduced body resistance, Reduced immunity, The state of immunodeficiency, Stimulation of the processes of nonspecific immunity, Severe secondary selective immunodeficiency, Inhibition of immunity, Primary immunodeficiency states

Z29.1 Prophylactic immunotherapy

Vaccination against viral infections,Vaccination of donors, Vaccination and revaccination, Vaccination of newborns, Vaccination against hepatitis B, Immunoprophylaxis, Correction of immune status,Treatment-prophylactic immunization, Preventive immunization, Specific immunoprophylaxis, Stimulation of the processes of nonspecific immunity

Composition

Tablets sublingual 1 tab.

Vincetoxicum hirundinaria D6 D10 D30 at 75 mg

Sulfur D4 D10, 37.5 mg

Magnesium stearate 1.5 mg

lactose

In polypropylene canisters of 50 pieces; In a pack of cardboard 1 pencil case.

pharmachologic effect

Pharmacological action - antiviral, immunomodulating, sympatholytic.

Clinical Pharmacology

In severe infectious conditions (severe fever, sepsis), the first dose of the drug may worsen the state of health for 3-5 hours.

Indications

As a means of activating nonspecific protective mechanisms of the body, with inflammatory and infectious diseases in adults (in complex therapy).

Contraindications

Hypersensitivity to the components of the drug.

Side effects

Allergic reactions.

Dosing and Administration

Sublingually, 1 tab. 3 times a day.

storage Conditions

In dry, the dark place at room temperature.

Keep out of the reach of children.

Shelf life

5 years.

Do not use after the expiry date printed on the package.